Rights and permissions
About this article
Cite this article
Abciximab reserved for high-risk patients in Asia. Pharmacoecon. Outcomes News 488, 6 (2005). https://doi.org/10.2165/00151234-200504880-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504880-00013